Published 2005
| Version v1
Journal article
The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.
- Others:
- Toxines bactériennes dans la relation hôtes-pathogènes ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA)
- Immunité muqueuse et vaccination ; Institut National de la Santé et de la Recherche Médicale (INSERM)
- Service d'Anatomo-Pathologie ; Centre Hospitalier Universitaire de Nice (CHU Nice)
Description
Cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli belongs to a family of factors activating Rho GTPases. We report the in vivo effects of CNF1 in mice co-fed toxin and the soluble protein antigen ovalbumin (OVA). Similar to cholera toxin, CNF1 elicits adjuvanticity anti-OVA responses, both systemic and mucosal. In contrast, the catalytic inactive mutant CNF1-C866S demonstrated no effects. Using dermonecrotic toxin (DNT), a closely related Rho activating toxin from Bordetella, we discovered that the adjuvant property is within the DNT catalytic domain. Manipulation of Rho proteins thus provides a possible new approach for the development of effective mucosal immunoadjuvants.
Additional details
- URL
- https://www.hal.inserm.fr/inserm-00000099
- URN
- urn:oai:HAL:inserm-00000099v1
- Origin repository
- UNICA